Free Trial

This company has been marked as potentially delisted and may not be actively trading.

NASDAQ:RAIN

Rain Oncology (RAIN) Stock Price, News & Analysis

Rain Oncology logo

About Rain Oncology Stock (NASDAQ:RAIN)

Advanced Chart
Remove Ads

Key Stats

Today's Range
$1.93
$2.19
50-Day Range
$1.20
$1.24
52-Week Range
$0.82
$11.32
Volume
46,981 shs
Average Volume
32,376 shs
Market Capitalization
$11.36 million
P/E Ratio
N/A
Dividend Yield
N/A
Price Target
N/A
Consensus Rating
N/A

Company Overview

As of January 26, 2024, operates as a subsidiary of Pathos AI, Inc.

Remove Ads
Receive RAIN Stock News and Ratings via Email

Sign-up to receive the latest news and ratings for Rain Oncology and its competitors with MarketBeat's FREE daily newsletter.

RAIN Stock News Headlines

Trump’s Secret Weapon
Have you looked at the stock market recently? Millions of investors are scrambling trying to figure out what's coming next. But here's the truth… This is just the beginning. Trump has made it clear his tariffs are coming, and that the market will get worse before it gets better. Luckily, our FREE Presidential Transition Guide details exactly what will happen in the next 100 days, and how to protect your hard-earned savings during these times. Don't wait for the next crash to wipe you out. Act now.
See More Headlines

RAIN Stock Analysis - Frequently Asked Questions

Rain Oncology Inc. (NASDAQ:RAIN) issued its quarterly earnings results on Wednesday, November, 10th. The company reported ($0.70) earnings per share (EPS) for the quarter, missing analysts' consensus estimates of ($0.64) by $0.06.

Rain Oncology (RAIN) raised $126 million in an initial public offering (IPO) on Friday, April 23rd 2021. The company issued 7,400,000 shares at a price of $16.00-$18.00 per share. Goldman Sachs, Citigroup, Piper Sandler and Guggenheim Securities served as the underwriters for the IPO.

Based on aggregate information from My MarketBeat watchlists, some other companies that Rain Oncology investors own include CRISPR Therapeutics (CRSP), Meta Platforms (META), UiPath (PATH), Recursion Pharmaceuticals (RXRX), Alibaba Group (BABA), NVIDIA (NVDA) and

Company Calendar

Last Earnings
11/10/2021
Today
4/04/2025
Fiscal Year End
12/31/2025

Industry, Sector and Symbol

Stock Exchange
NASDAQ
Industry
Holding & other investment offices
Sub-Industry
N/A
Current Symbol
NASDAQ:RAIN
Fax
N/A
Employees
63
Year Founded
N/A

Profitability

Trailing P/E Ratio
N/A
Forward P/E Ratio
N/A
P/E Growth
N/A
Net Income
$3.10 million
Pretax Margin
N/A

Debt

Sales & Book Value

Annual Sales
N/A
Cash Flow
$0.28 per share
Price / Cash Flow
7.41
Book Value
($0.69) per share
Price / Book
-2.97

Miscellaneous

Free Float
4,574,000
Market Cap
$11.36 million
Optionable
No Data
Beta
-0.11
10 Stocks Set to Soar in Spring 2025 Cover

Market volatility creates opportunity. Our analysts have pinpointed 10 stocks perfectly positioned for exceptional growth this spring, even amid economic uncertainty. Don't miss your chance to access this timely research and invest with confidence.

Get This Free Report

This page (NASDAQ:RAIN) was last updated on 4/4/2025 by MarketBeat.com Staff
From Our Partners